Skip to content

Drug interactions

Lidocaine-prilocaine + Lomitapide

Severity: Minor

Lidocaine-prilocaine and Lomitapide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide exposure rises markedly with strong or moderate CYP3A4 inhibitors, which raises the risk of hepatotoxicity. Topical lidocaine-prilocaine gives low systemic lidocaine levels and is not a meaningful CYP3A4 inhibitor, so a relevant effect is unlikely.

What this interaction means in plain words

Lidocaine-prilocaine and Lomitapide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lidocaine-prilocaine belongs to Genitourinary; Lomitapide belongs to Cardiovascular.

Evidence level: Low

Why it happens

Lidocaine is a CYP3A4 substrate with negligible inhibitory effect at topical exposure.

What to do

No dose change is needed for standard topical use. Continue routine liver enzyme monitoring for lomitapide.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lidocaine-prilocaine and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lidocaine-prilocaine with Lomitapide?

MediHelp rates the interaction as minor. Lidocaine-prilocaine and Lomitapide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lomitapide exposure rises markedly with strong or moderate CYP3A4 inhibitors, which raises the risk of hepatotoxicity. Topical lidocaine-prilocaine gives low systemic lidocaine levels and is not a meaningful CYP3A4 inhibitor, so a relevant effect is unlikely.

How serious is the interaction between Lidocaine-prilocaine and Lomitapide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed for standard topical use. Continue routine liver enzyme monitoring for lomitapide.

What other medicines interact with Lidocaine-prilocaine?

MediHelp also lists interactions of Lidocaine-prilocaine with, for example, Phenazopyridine, Bupivacaine implant, Bupivacaine liposome. The full list is on the Lidocaine-prilocaine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in